
Osborne Head & Neck Institute | Los Angeles
A Comprehensive Guide to Diagnosis, Anatomy, and Advanced Surgical Treatment
Ryan F. Osborne, MD, FACS | Fellowship-Trained Head & Neck Surgical Oncologist
Medically Reviewed By: OHNI Clinical Staff · Last Updated: November 2, 2026
Overview
Deep lobe parotid tumors are rare salivary gland tumors that arise from the portion of the parotid gland located deep to the facial nerve. Unlike more common superficial parotid tumors, which present as visible or palpable masses near the jawline, deep lobe tumors often remain hidden, sometimes growing significantly before detection.
The parotid gland is divided into two main parts: the superficial lobe (located above the facial nerve) and the deep lobe (located beneath the facial nerve and extending toward the throat). Approximately 10% of all parotid tumors originate in the deep lobe, making them uncommon but clinically significant.
Because of their position, deep lobe tumors may extend into the parapharyngeal space, a deep region of the neck adjacent to the airway and vital neurovascular structures. This creates unique challenges in both diagnosis and treatment.
Unique Challenges

Deep lobe tumors are often referred to as "hidden tumors" because they do not always present with visible swelling and may grow inward toward the throat.
The deep lobe lies in close proximity to several critical structures, increasing surgical complexity.
Anatomy
The parapharyngeal space (PPS) is a deep neck compartment shaped like an inverted pyramid, extending from the skull base to the hyoid bone. PPS tumors account for less than 1% of all head and neck tumors.
This space is divided into the prestyloid compartment (salivary gland origin) and the poststyloid compartment (neurogenic origin). Deep lobe parotid tumors arise in the prestyloid space and are most commonly salivary in origin.

Classification
70–80% of parapharyngeal space tumors are benign; 20–30% are malignant.
The majority of deep lobe tumors are benign. The most common is pleomorphic adenoma, a slow-growing tumor that may become very large if untreated.
A smaller percentage of deep lobe tumors are malignant. Common types include:
Symptoms
Because of their location, symptoms may differ significantly from superficial parotid tumors.
Diagnosis
Deep lobe tumors are often difficult to detect because they are not easily visible externally, may not be palpable, and symptoms can be subtle. Imaging plays a central role in diagnosis.

Provides excellent soft tissue detail and identifies tumor relationship to the parotid gland.
Useful for evaluating bone involvement and assessing malignant features.
Unlike superficial tumors, biopsy is often avoided initially because the tumor may be highly vascular or close to major blood vessels. Imaging alone is often sufficient to guide surgical planning.
Treatment
Surgical removal is the standard of care. The goals include complete tumor removal, facial nerve preservation, and protection of vital structures.

The most commonly used approach that allows direct access to the tumor, identification and preservation of the facial nerve, and safe removal without unnecessary disruption.
Historically, some surgeons performed mandibulotomy (splitting the jaw) to access deep tumors. Modern techniques have made this largely unnecessary, significantly reducing recovery time and morbidity.
The facial nerve must be carefully identified and protected throughout surgery to prevent facial paralysis.
Incomplete removal increases the risk of recurrence and, in some tumors, malignant transformation.
Surgeons must navigate around the carotid artery, jugular vein, and cranial nerves with precision.
Outcomes

Real Patients. Real Outcomes.
Each story reflects what matters most: accurate diagnosis, thoughtful treatment, and outcomes that restore both function and confidence.
Hear From Our Patients
Patients travel from across the United States and around the globe for salivary gland and parotid surgery at the Osborne Head & Neck Institute. Find a story from your state or country and see what the journey looked like for someone in your position.
View Patient TestimonialsExpertise
Deep lobe parotid tumors are among the most technically demanding cases in head and neck surgery. Their hidden location, proximity to critical structures, and need for precise dissection require extensive experience.

PATIENT EDUCATION
No. With modern techniques, most deep lobe tumors can be removed without mandibulotomy, reducing recovery time and complications.
Most are benign, but a small percentage are malignant. Imaging and pathology determine the diagnosis.
They are typically identified through imaging (MRI or CT) after symptoms develop, such as a growing mass or parapharyngeal space fullness.
Yes. Surgical removal is the standard treatment for both benign and malignant deep lobe parotid tumors.
The tumor's location beneath the facial nerve and near critical structures like the internal carotid artery requires highly specialized surgical expertise and careful preoperative planning.
Philosophy
Deep lobe tumors require a highly specialized approach that prioritizes complete tumor removal and preservation of function.
Even in complex cases, the goal is to limit unnecessary disruption, avoid aggressive approaches like jaw splitting, and optimize recovery.
Each case is unique. Treatment is individually planned based on tumor characteristics and tailored to patient needs.
Further Reading

Why Choose OHNI
Many patients assume the best care is found at large, well-known institutions. While these centers offer excellent care, they often operate within standardized systems shaped by regional training models.
At OHNI, Dr. Ryan Osborne offers something fundamentally different: a truly global perspective combined with highly personalized surgical care with experience across five continents, tailoring each procedure to the individual patient, not the system.
Experience across five continents, applying diverse surgical philosophies and techniques beyond standard U.S. training.
Specialized techniques like Extra-Capsular Dissection designed to minimize invasiveness while protecting the facial nerve.
Direct surgeon access, individualized treatment planning, and a focus on both medical outcomes and quality of life.
Patients consistently highlight clear communication, confident surgical decisions, and excellent functional results.
Deep lobe parotid tumors require specialized evaluation and surgical expertise. Early evaluation allows for accurate diagnosis, safer treatment, and better outcomes.
Contact the Osborne Head & Neck Institute for expert evaluation and surgical planning.